These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 12189254

  • 21. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM.
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [Abstract] [Full Text] [Related]

  • 22. An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.
    Mischoulon D, Dougherty DD, Bottonari KA, Gresham RL, Sonawalla SB, Fischman AJ, Fava M.
    Psychiatry Res; 2002 Dec 30; 116(3):151-61. PubMed ID: 12477599
    [Abstract] [Full Text] [Related]

  • 23. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.
    J Clin Psychiatry; 2011 Oct 30; 72(10):1405-12. PubMed ID: 21367355
    [Abstract] [Full Text] [Related]

  • 24. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Oct 30; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 25. Nefazodone in out-patient treatment of inhaled cocaine dependence: a randomized double-blind placebo-controlled trial.
    Passos SR, Camacho LA, Lopes CS, dos Santos MA.
    Addiction; 2005 Apr 30; 100(4):489-94. PubMed ID: 15784063
    [Abstract] [Full Text] [Related]

  • 26. Fluoxetine for hypochondriacal patients without major depression.
    Fallon BA, Liebowitz MR, Salmán E, Schneier FR, Jusino C, Hollander E, Klein DF.
    J Clin Psychopharmacol; 1993 Dec 30; 13(6):438-41. PubMed ID: 8120157
    [Abstract] [Full Text] [Related]

  • 27. Nefazodone for social phobia: a clinical case series.
    Worthington JJ, Zucker BG, Fones CS, Otto MW, Pollack MH.
    Depress Anxiety; 1998 Dec 30; 8(3):131-3. PubMed ID: 9836065
    [Abstract] [Full Text] [Related]

  • 28. Nefazodone in social phobia.
    Van Ameringen M, Mancini C, Oakman JM.
    J Clin Psychiatry; 1999 Feb 30; 60(2):96-100. PubMed ID: 10084635
    [Abstract] [Full Text] [Related]

  • 29. Case study: nefazodone for juvenile mood disorders.
    Wilens TE, Spencer TJ, Biederman J, Schleifer D.
    J Am Acad Child Adolesc Psychiatry; 1997 Apr 30; 36(4):481-5. PubMed ID: 9100422
    [Abstract] [Full Text] [Related]

  • 30. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
    Youssef NA, Marx CE, Bradford DW, Zinn S, Hertzberg MA, Kilts JD, Naylor JC, Butterfield MI, Strauss JL.
    Int Clin Psychopharmacol; 2012 Jul 30; 27(4):191-6. PubMed ID: 22475888
    [Abstract] [Full Text] [Related]

  • 31. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
    Sánchez-Lacay JA, Lewis-Fernández R, Goetz D, Blanco C, Salmán E, Davies S, Liebowitz M.
    Depress Anxiety; 2001 Jul 30; 13(3):118-24. PubMed ID: 11387731
    [Abstract] [Full Text] [Related]

  • 32. Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
    Van Ameringen M, Mancini C, Oakman J, Walker J, Kjernisted K, Chokka P, Johnston D, Bennett M, Patterson B.
    J Clin Psychiatry; 2007 Feb 30; 68(2):288-95. PubMed ID: 17335328
    [Abstract] [Full Text] [Related]

  • 33. The safety profile of nefazodone.
    Robinson DS, Roberts DL, Smith JM, Stringfellow JC, Kaplita SB, Seminara JA, Marcus RN.
    J Clin Psychiatry; 1996 Feb 30; 57 Suppl 2():31-8. PubMed ID: 8626361
    [Abstract] [Full Text] [Related]

  • 34. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar 30; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 35. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U.
    J Clin Psychiatry; 1995 Mar 30; 56 Suppl 6():37-42. PubMed ID: 7649972
    [Abstract] [Full Text] [Related]

  • 36. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D, Hooper CL, Thornton MD, Wiens A, Miller CA, Thibaudeau CA.
    Int Clin Psychopharmacol; 1997 Mar 30; 12(2):91-7. PubMed ID: 9219044
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
    Wynchank D, Berk M.
    Hum Psychopharmacol; 2003 Jun 30; 18(4):271-5. PubMed ID: 12766931
    [Abstract] [Full Text] [Related]

  • 38. Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.
    Shoval G, Nahshoni E, Gothelf D, Manor I, Golobchik P, Zemishlany Z, Weizman A, Zalsman G.
    Clin Neuropharmacol; 2011 Jun 30; 34(5):182-5. PubMed ID: 21926484
    [Abstract] [Full Text] [Related]

  • 39. Nefazodone in post-traumatic stress disorder: results from six open-label trials.
    Hidalgo R, Hertzberg MA, Mellman T, Petty F, Tucker P, Weisler R, Zisook S, Chen S, Churchill E, Davidson J.
    Int Clin Psychopharmacol; 1999 Mar 30; 14(2):61-8. PubMed ID: 10220119
    [Abstract] [Full Text] [Related]

  • 40. Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial.
    Avila A, Cardona X, Martin-Baranera M, Maho P, Sastre F, Bello J.
    J Clin Psychopharmacol; 2003 Oct 30; 23(5):509-13. PubMed ID: 14520130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.